Antiemetic Strategies in Patients Who Undergo Hematopoietic Stem Cell Transplantation
Abstract Hematopoietic stem cell transplantation (HSCT) is an integral part of the treatment strategy in patients with a hematological disorder. Chemotherapy-induced nausea and vomiting (CINV) is still an issue in patients who undergo HSCT. While several guidelines for the antiemetic therapy against...
Gorde:
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
SAABRON PRESS
2022-07-01
|
| Saila: | Clinical Hematology International |
| Gaiak: | |
| Sarrera elektronikoa: | https://doi.org/10.1007/s44228-022-00012-8 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|